{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:16:57Z","timestamp":1789834617474,"version":"4.0.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The retained products of conception (RPOC) and related conditions (RPOC-ARC) are the main cause of secondary postpartum hemorrhage (sPPH), but there is no clear consensus for their management. The purpose of this study was to characterize those RPOC-ARC that require invasive treatment and those that could be managed more conservatively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively analyzed 96 cases of RPOC-ARC that occurred after miscarriage, abortion, or delivery at a gestational age between 12 and 42 completed weeks, that were managed within our institution from May 2015 to August 2020. We reviewed the associations between the occurrence of sPPH requiring invasive treatment with clinical factors such as the maternal background and the characteristics of the lesions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The range of gestational age at delivery in our study was 12\u201321\u2009weeks in 61 cases, 22\u201336 in 5, and 37 or later in 30. Among them, nine cases required invasive procedures for treatment. The onset of sPPH was within one month of delivery in all but two cases, with a median of 24\u2009days (range 9\u201347). We found significant differences between requirements for invasive versus non-invasive strategies according to gestational age at delivery, assisted reproductive technology (ART) pregnancy, amount of blood loss at delivery, and the long axis of the RPOC-ARC lesion (<jats:italic>p<\/jats:italic>\u2009=\u20090.028, <jats:italic>p<\/jats:italic>\u2009=\u20090.009, <jats:italic>p<\/jats:italic>\u2009=\u20090.004, and <jats:italic>p<\/jats:italic>\u2009=\u20090.002, respectively). Multivariate analysis showed that only the long axis of the lesion showed a significant difference (<jats:italic>p<\/jats:italic>\u2009=\u20090.029). The Receiver Operating Characteristic (ROC) curve for predicting the need for invasive strategies using the long axis of the lesion showed that with a cutoff of 4.4\u2009cm, the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) was 87.5, 90.0, 43.8, and 98.7%, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The long axis of the RPOC-ARC is a simple indicator for predicting which sPPH will require invasive procedures, which use is rare in cases with lesions less than 4.4\u2009cm or those occurring after the first postpartum month. Conservative management should be considered in such cases.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-021-04083-y","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T16:35:48Z","timestamp":1632501348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The RPOC long axis is a simple indicator for predicting the need of invasive strategies for secondary postpartum hemorrhage in either post-abortion or post-partum women: a retrospective case control study"],"prefix":"10.1186","volume":"21","author":[{"given":"Mariya","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Kawanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahide","family":"Maenaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aska","family":"Toda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Hiramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Mimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,24]]},"reference":[{"key":"4083_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/AOG.0000000000002351","volume":"130","author":"ACOG","year":"2017","unstructured":"ACOG. Clinical management guidelines for obstetrician \u2013 gynecologists. Obstet Gynecol. 2017;130:168\u201386.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"4083_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/birt.12164","volume":"42","author":"M Dossou","year":"2015","unstructured":"Dossou M, Debost-Legrand A, D\u00e9chelotte P, L\u00e9mery D, Vendittelli F. Severe secondary postpartum hemorrhage: a historical cohort. Birth. 2015;42(2):149\u201355. https:\/\/doi.org\/10.1111\/birt.12164.","journal-title":"Birth."},{"key":"4083_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S2214-109X(14)70227-X","volume":"2","author":"L Say","year":"2014","unstructured":"Say L, Chou D, Gemmill A, Tun\u00e7alp \u00d6, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Heal. 2014;2:323\u201333.","journal-title":"Lancet Glob Heal"},{"issue":"5","key":"4083_CR4","doi-asserted-by":"publisher","first-page":"E119","DOI":"10.1213\/ANE.0000000000004424","volume":"130","author":"SC Reale","year":"2020","unstructured":"Reale SC, Easter SR, Xu X, Bateman BT, Farber MK. Trends in postpartum hemorrhage in the United States from 2010 to 2014. Anesth Analg. 2020;130(5):E119\u201322. https:\/\/doi.org\/10.1213\/ANE.0000000000004424.","journal-title":"Anesth Analg"},{"issue":"4","key":"4083_CR5","first-page":"207","volume":"9","author":"J De Winter","year":"2017","unstructured":"De Winter J, De Raedemaecker H, Muys J, Jacquemyn Y. The value of postpartum ultrasound for the diagnosis of retained products of conception: a systematic review. Facts Views Vis ObGyn. 2017;9(4):207\u201316.","journal-title":"Facts Views Vis ObGyn"},{"issue":"3","key":"4083_CR6","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ijgo.2010.03.036","volume":"110","author":"E Cosmi","year":"2010","unstructured":"Cosmi E, Saccardi C, Litta P, Nardelli GB, Dessole S. Transvaginal ultrasound and sonohysterography for assessment of postpartum residual trophoblastic tissue. Int J Gynecol Obstet. 2010;110(3):262\u20134. https:\/\/doi.org\/10.1016\/j.ijgo.2010.03.036.","journal-title":"Int J Gynecol Obstet"},{"issue":"2","key":"4083_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.contraception.2020.04.014","volume":"102","author":"K Mimura","year":"2020","unstructured":"Mimura K, Endo M, Kakigano A, Matsuzaki S, Kawanishi Y, Tomimatsu T, et al. Sonographic findings after induced medical abortion at 12\u201321 weeks of gestation: retrospective cohort study. Contraception. 2020;102(2):87\u201390. https:\/\/doi.org\/10.1016\/j.contraception.2020.04.014.","journal-title":"Contraception."},{"key":"4083_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ejogrb.2019.06.016","volume":"240","author":"H Takahashi","year":"2019","unstructured":"Takahashi H, Ohhashi M, Baba Y, Nagayama S, Ogoyama M, Horie K, et al. Conservative management of retained products of conception in the normal placental position: a retrospective observational study. Eur J Obstet Gynecol Reprod Biol. 2019;240:87\u201392. https:\/\/doi.org\/10.1016\/j.ejogrb.2019.06.016.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"4083_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jogoh.2018.12.005","volume":"48","author":"P Capmas","year":"2019","unstructured":"Capmas P, Lobersztajn A, Duminil L, Barral T, Pourcelot AG, Fernandez H. Operative hysteroscopy for retained products of conception: efficacy and subsequent fertility. J Gynecol Obstet Hum Reprod. 2019;48(3):151\u20134. https:\/\/doi.org\/10.1016\/j.jogoh.2018.12.005.","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"6","key":"4083_CR10","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jmig.2011.08.003","volume":"18","author":"DT Rein","year":"2011","unstructured":"Rein DT, Schmidt T, Hess AP, Volkmer A, Sch\u00f6ndorf T, Breidenbach M. Hysteroscopic Management of Residual Trophoblastic Tissue is Superior to ultrasound-guided curettage. J Minim Invasive Gynecol. 2011;18(6):774\u20138. https:\/\/doi.org\/10.1016\/j.jmig.2011.08.003.","journal-title":"J Minim Invasive Gynecol"},{"key":"4083_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ejogrb.2013.11.020","volume":"173","author":"N Smorgick","year":"2014","unstructured":"Smorgick N, Barel O, Fuchs N, Ben-Ami I, Pansky M, Vaknin Z. Hysteroscopic management of retained products of conception: Meta-analysis and literature review. Eur J Obstet Gynecol Reprod Biol. 2014;173:19\u201322. https:\/\/doi.org\/10.1016\/j.ejogrb.2013.11.020.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"4083_CR12","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s00270-016-1543-7","volume":"40","author":"P Bazeries","year":"2017","unstructured":"Bazeries P, Paisant-Thouveny F, Yahya S, Bouvier A, Nedelcu C, Boussion F, et al. Uterine artery embolization for retained products of conception with marked vascularity: a safe and efficient first-line treatment. Cardiovasc Intervent Radiol. 2017;40(4):520\u20139. https:\/\/doi.org\/10.1007\/s00270-016-1543-7.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"4083_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s42155-020-00107-4","volume":"3","author":"Y Kimura","year":"2020","unstructured":"Kimura Y, Osuga K, Nagai K, Hongyo H, Tanaka K, Ono Y, et al. The efficacy of uterine artery embolization with gelatin sponge for retained products of conception with bleeding and future pregnancy outcomes. CVIR Endovasc. 2020;3(1):13. https:\/\/doi.org\/10.1186\/s42155-020-00107-4.","journal-title":"CVIR Endovasc"},{"key":"4083_CR14","doi-asserted-by":"publisher","unstructured":"Youssef A, Brunelli E, Modestino F. Three-dimensional color Doppler before and after embolization of postpartum-acquired enhanced myometrial vascularity\/arteriovenous malformation. Am J Obstet Gynecol. 2020; Figure 4:1\u20134. doi:https:\/\/doi.org\/10.1016\/j.ajog.2020.05.002.","DOI":"10.1016\/j.ajog.2020.05.002"},{"issue":"2","key":"4083_CR15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3348\/kjr.2017.18.2.355","volume":"18","author":"HK Ko","year":"2017","unstructured":"Ko HK, Shin JH, Ko GY, Il GD, Kim JH, Han K, et al. Efficacy of prophylactic uterine artery embolization before obstetrical procedures with high risk for massive bleeding. Korean J Radiol. 2017;18(2):355\u201360. https:\/\/doi.org\/10.3348\/kjr.2017.18.2.355.","journal-title":"Korean J Radiol"},{"issue":"2","key":"4083_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.11648\/j.jgo.20160402.11","volume":"4","author":"H Naoi","year":"2016","unstructured":"Naoi H, Kumasawa K, Nakamura H, Nishikawa A, Kimura T, et al. Investigation of the prognosis of 28 patients with retained placenta after delivery. J Gynecol Obstet. 2016;4(2):7. https:\/\/doi.org\/10.11648\/j.jgo.20160402.11.","journal-title":"J Gynecol Obstet"},{"issue":"12","key":"4083_CR17","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1007\/s00261-016-0954-x","volume":"41","author":"A Kamaya","year":"2016","unstructured":"Kamaya A, Krishnarao PM, Nayak N, Jeffrey RB, Maturen KE. Clinical and imaging predictors of management in retained products of conception. Abdom Radiol. 2016;41(12):2429\u201334. https:\/\/doi.org\/10.1007\/s00261-016-0954-x.","journal-title":"Abdom Radiol"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-04083-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-021-04083-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-04083-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T16:35:55Z","timestamp":1632501355000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-021-04083-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4083"],"URL":"https:\/\/doi.org\/10.1186\/s12884-021-04083-y","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,24]]},"assertion":[{"value":"17 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Osaka University Hospital (No.21007). Informed consent was obtained from each patient or her authorized representatives. The study was performed in accordance with the Declaration of Helsinki ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"653"}}